Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles

Journal of Neuroscience Methods

Volumn 177, Issue 1, 2009, Pages 177-182

  Volz, Trent J ^a   Farnsworth, Sarah J ^a   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Dopamine; In vitro; Methylphenidate; Rotating disk electrode voltammetry; Vesicular monoamine transporter 2

Indexed keywords

DOPAMINE; METHYLPHENIDATE; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; IMMUNOREACTIVITY; INCUBATION TIME; MALE; MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; SYNAPTOSOME; TECHNIQUE; UPREGULATION; VALIDATION PROCESS;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHYLPHENIDATE; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS; SYNAPTIC VESICLES; SYNAPTOSOMES; TIME FACTORS; UP-REGULATION; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 58049200556     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2008.10.004     Document Type: Article

References (26)

1. Bretz U., Baggiolini M., Hauser R., and Hodel C. Resolution of three distinct populations of nerve endings from rat brain homogenates by zonal isopycnic centrifugation. J Cell Biol 61 (1974) 466-480
2. Chapin D.S., Lookingland K.J., and Moore K.E. Effects of LC mobile phase composition on retention times for biogenic amines, and their precursors and metabolites. Curr Sep 7 (1986) 68-70
3. Earles C., Wayment H., Green M., and Schenk J.O. Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: methodology and mechanistic interpretations. Methods Enzymol 296 (1998) 660-675
4. Easton N., Steward C., Marshall F., Fone K., and Marsden C. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Neuropharmacology 52 (2007) 405-414
5. Fersht A. Structure and mechanism in protein science: a guide to enzyme catalysis and protein folding (1998), W. H. Freeman and Company, New York
6. Kim S., Westphalen R., Callahan B., Hatzidimitriou G., Yuan J., and Ricaurte G.A. Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity. J Pharmacol Exp Ther 293 (2000) 625-633
7. Lackington I., and Orrego F. Continuous measurement of net potassium movements in rat brain cortex suspensions. Effects of glutamate, veratridine, creatine and other substances. Brain Res 378 (1986) 390-393
8. Lescot T., Degos V., and Puybasset L. Does the brain become heavier or lighter after trauma?. Eur J Anaesthesiol Suppl 42 (2008) 110-114
9. McElvain J.S., and Schenk J.O. Blockade of dopamine autoreceptors by haloperidol and the apparent dynamics of potassium-stimulated endogenous release of dopamine from and reuptake into striatal suspensions in the rat. Neuropharmacology 31 (1992) 649-659
10. Motulsky H.J., and Christopoulos A. Fitting models to biological data using linear and non-linear regression: a practical guide to curve fitting. 2nd ed. (2003), GraphPad Software, Inc., San Diego
11. Patrick K.S., Ellington K.R., and Breese G.R. Distribution of methylphenidate and p-hydroxymethylphenidate in rats. J Pharmacol Exp Ther 231 (1984) 61-65
12. Riddle E.L., Hanson G.R., and Fleckenstein A.E. Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. Eur J Pharmacol 571 (2007) 25-28
13. Riddle E.L., Topham M.K., Haycock J.W., Hanson G.R., and Fleckenstein A.E. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur J Pharmacol 449 (2002) 71-74
14. Sabatini U., Celsis P., Viallard G., Rascol A., and Marc-Vergnes J.P. Quantitative assessment of cerebral blood volume by single-photon emission computed tomography. Stroke 22 (1991) 324-330
15. Sandoval V., Riddle E.L., Hanson G.R., and Fleckenstein A.E. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. J Neurosci 22 (2002) 8705-8710
16. Sandoval V., Riddle E.L., Ugarte Y.V., Hanson G.R., and Fleckenstein A.E. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J Neurosci 21 (2001) 1413-1419
17. Schenk J.O., Wright C., and Bjorklund N. Unraveling neuronal dopamine transporter mechanisms with rotating disk electrode voltammetry. J Neurosci Methods 143 (2005) 41-47
18. Segel I.H. Enzyme kinetics: behavior and analysis of rapid equilibrium and steady-state enzyme systems (1993), John Wiley and Sons, Inc., New York p. 18-99
19. Thai D.L., Yurasits L.N., Rudolph G.R., and Perel J.M. Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogs. Drug Metab Dispos 27 (1999) 645-650
20. Truong J.G., Newman A.H., Hanson G.R., and Fleckenstein A.E. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein. Eur J Pharmacol 504 (2004) 27-32
21. Volz T.J., Bjorklund N.L., and Schenk J.O. Methylphenidate analogs with behavioral differences interact differently with arginine residues on the dopamine transporter in rat striatum. Synapse 57 (2005) 175-178
22. Volz T.J., Farnsworth S.J., King J.L., Riddle E.L., Hanson G.R., and Fleckenstein A.E. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. J Pharmacol Exp Ther 323 (2007) 738-745
23. Volz T.J., Farnsworth S.J., Rowley S.D., Hanson G.R., and Fleckenstein A.E. Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors. J Pharmacol Exp Ther 327 (2008) 161-167
24. Volz T.J., Hanson G.R., and Fleckenstein A.E. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry. J Neurosci Methods 155 (2006) 109-115
25. Volz T.J., and Schenk J.O. A comprehensive atlas of the topography of functional groups of the dopamine transporter. Synapse 58 (2005) 72-94
26. Wayment H.K., Deutsch H., Schweri M.M., and Schenk J.O. Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists?. J Neurochem 72 (1999) 1266-1274